Pathstone Holdings
CORZ icon

Pathstone Holdings’s Core Scientific CORZ Stock Holding History

Pathstone Holdings’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Sell
15,706
-6,908
-31% -$163K ﹤0.01% 1978
2026
Q1 		$338K Hold
22,614
– – ﹤0.01% 1922
2025
Q4 		$329K Sell
22,614
-53,480
-70% -$933K ﹤0.01% 1920
2025
Q3 		$1.37M Buy
76,094
+967
+1% +$14.2K 0.01% 1251
2025
Q2 		$1.28M Buy
75,127
+11,164
+17% +$112K 0.01% 1262
2025
Q1 		$463K Buy
+63,963
New +$728K ﹤0.01% 1750
2024
Q4 		– Sell
-87,658
Closed -$1.04M – 2325
2024
Q3 		$1.04M Sell
87,658
-271,156
-76% -$2.81M ﹤0.01% 1350
2024
Q2 		$3.34M Buy
358,814
+107,202
+43% +$548K 0.02% 684
2024
Q1 		$891K Buy
+251,612
New +$872K ﹤0.01% 1352

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Pathstone Holdings's CORZ Position: Q2 2026 in Review

Pathstone Holdings reduced its Core Scientific (CORZ) stake by 31% in Q2 2026, selling an estimated $163K and leaving 15,706 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Pathstone Holdings first reported a position in CORZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.34M in Q2 2024. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Pathstone Holdings held 15,706 shares of Core Scientific worth $402K as of Q2 2026.
  • Pathstone Holdings sold 6,908 Core Scientific shares in Q2 2026, an estimated $163K.
  • Core Scientific made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1978 holding.
  • Pathstone Holdings first reported a position in Core Scientific in Q1 2024 and has held it in 9 quarters since.
  • Pathstone Holdings's Core Scientific position peaked at $3.34M in Q2 2024.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.